Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $16.89 down -3.38% from its previous closing price of $17.48. In other words, the price has decreased by -$3.38 from its previous closing price. On the day, 11.46 million shares were traded. TEVA stock price reached its highest trading level at $17.5 during the session, while it also had its lowest trading level at $16.68.
Ratios:
For a deeper understanding of Teva- Pharmaceutical Industries Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.29. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 2.71 whereas as Long-Term Debt/Eq ratio is at 2.64.
On July 10, 2024, Argus Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $20.
JP Morgan Upgraded its Underweight to Neutral on March 08, 2024, while the target price for the stock was maintained at $14.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 08 ’25 when Sabag Mark sold 337,915 shares for $18.04 per share. The transaction valued at 6,097,304 led to the insider holds 150,996 shares of the business.
Sabag Mark bought 337,915 shares of TEVA for $6,097,324 on May 08 ’25. On Mar 05 ’25, another insider, Daniell Richard, who serves as the Exec. VP, European Commercial of the company, sold 70,961 shares for $15.91 each. As a result, the insider received 1,128,642 and left with 48,384 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 19587670016 and an Enterprise Value of 34621153280. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 3.09. Its current Enterprise Value per Revenue stands at 2.084 whereas that against EBITDA is 7.777.
Stock Price History:
The Beta on a monthly basis for TEVA is 0.62, which has changed by 0.03619635 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $12.47. The 50-Day Moving Average of the stock is 9.67%, while the 200-Day Moving Average is calculated to be -3.68%.
Shares Statistics:
For the past three months, TEVA has traded an average of 12.81M shares per day and 17109950 over the past ten days. A total of 1.15B shares are outstanding, with a floating share count of 1.14B. Insiders hold about 0.25% of the company’s shares, while institutions hold 62.71% stake in the company. Shares short for TEVA as of 1745971200 were 28426081 with a Short Ratio of 2.22, compared to 1743379200 on 32386482. Therefore, it implies a Short% of Shares Outstanding of 28426081 and a Short% of Float of 2.4899999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.95.
